BSTZ (BSTZ) Stock Price & Analysis
BSTZ (BSTZ) fell 1.28% to USD 29.23 as of June 10, 2026 at 00:51 UTC, according to Nexqual real-time market data.
BSTZ last closed at USD 29.61; the session ranged USD 28.6–30.49 on volume of 155,786 shares. Market capitalization is $2.01B, with a 52-week range of USD 19.23–31.58 (NYQ). Source: Nexqual, June 10, 2026 at 00:51 UTC.
Key Statistics (as of June 10, 2026 at 00:51 UTC)
| Price | USD 29.23 |
|---|---|
| Change | ▼ 1.28% (down) |
| Previous Close | USD 29.61 |
| Open | USD 30.2 |
| Day Range | USD 28.6 – 30.49 |
| 52-Week Range | USD 19.23 – 31.58 |
| Volume | 155,786 shares |
| Market Cap | $2.01B |
| Exchange | NYQ |
Technical Analysis (BSTZ)
Nexqual's technical model rates BSTZ "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 00:51 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 53.52 (neutral) |
| vs SMA50 | Above (USD 26.67) |
| MACD | 0.94 (positive) |
Analyst Ratings (BSTZ)
Wall Street analysts rate BSTZ "None", per Nexqual as of June 10, 2026 at 00:51 UTC.
| Consensus Rating | None |
|---|
Earnings (BSTZ)
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financials & Fundamentals (BSTZ)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financial Health Score (BSTZ)
Nexqual rates BSTZ's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:51 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (BSTZ)
| Insider Ownership | +0.01% |
|---|---|
| Institutional Ownership | +30.89% |
| Shares Outstanding | 68.74M |
| Short % of Float | +0.16% |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Major Backers & Investors (BSTZ)
Notable institutional backers of BSTZ include Saba Capital Management, L.P., Morgan Stanley, Invesco, according to Nexqual as of June 10, 2026 at 00:51 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Saba Capital Management, L.P. | 8.12% |
| Morgan Stanley | 4.96% |
| Invesco | 2.75% |
| Exchange Listed Funds Trust-Saba Closed-End Funds ETF | 2.26% |
| RiverNorth Capital Management, LLC | 2.17% |
| UBS Group AG | 1.75% |
| Raymond James Financial, Inc. | 1.42% |
| Bank of America Corporation | 1.35% |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BMEZ | BlackRock Health Sciences Trust | USD 14.29 | ▼ 0.28% |
| BST | BlackRock Science and Technolog | USD 46.06 | ▲ 0.09% |
| AIO | AllianzGI Artificial Intelligen | USD 26.13 | ▼ 0.53% |
| BCAT | BlackRock Capital Allocation Term Trust | USD 15.6 | ▲ 0.91% |
| BME | Blackrock Health Sciences Trust | USD 40.48 | ▲ 1.35% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:51 UTC. This page is informational and not investment advice.